Zion: Animal auto-immune Dx to grow 4.2%
by Katie Pfaff
The global market for animal auto-immune disease diagnostics was predicted to reach $5 billion by 2028, according to report by market analysts, Zion Market Research. The growth rate since the 2021 value of $3.4 billion was predicted to reach a CAGR of 4.2% for the forecast period of 2022 to 2028.
Growth was forecast in the market as rates of zoonotic disease in animals with compromised immune systems have increased around the world. Concern for animal to human transmission of disease has also spurred some growth in the market. Another factor underpinning growth is the demand for animal protein for consumption and the subsequent expectation that the meat is tested and safe.
Potentially slowing growth in the market are the high costs of testing, typically due to the equipment required for testing, and relatively low number of veterinary professionals experienced and skilled in conducting such testing.
However, as immunoassay technology continues to take hold globally, the market is expected to benefit.
North America is predicted to take the largest share of the market as the region has already invested in infrastructure to manage animal healthcare. Costs with animal care have also decreased as a result of surveillance or early management of disease
Comments
Related Articles
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment